BioRestorative Therapies (NASDAQ:BRTX) Releases Earnings Results, Beats Expectations By $0.07 EPS

BioRestorative Therapies (NASDAQ:BRTX) announced its quarterly earnings data on Thursday. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.07, Zacks reports. The firm had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.48 million. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%.

BioRestorative Therapies Stock Down 1.1 %

Shares of BioRestorative Therapies stock opened at $1.81 on Friday. The company has a market capitalization of $12.53 million, a price-to-earnings ratio of -1.18 and a beta of 64.37. The stock’s 50-day simple moving average is $1.97 and its 200-day simple moving average is $1.72. BioRestorative Therapies has a 52 week low of $1.03 and a 52 week high of $2.55.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.